These three dividend stocks are worth a close look for their solid business quality and attractive payouts. In a market where income investors have options, the 10-year Treasury yield of 4.2% serves as a "risk-free" rate. It represents the guaranteed return on government debt where principal loss is virtually non-existent. To compete with the relatively high rate, a dividend stock must offer price...
These three dividend stocks are worth a close look for their solid business quality and attractive payouts. In a market where income investors have options, the 10-year Treasury yield of 4.2% serves as a "risk-free" rate. It represents the guaranteed return on government debt where principal loss is virtually non-existent. To compete with the relatively high rate, a dividend stock must offer price appreciation and growth potential backed by solid coverage ratios. These three companies fit that bill. Trading members for pricing discipline UnitedHealth Group (UNH +2.03%) operates the nation's largest private health insurer, alongside Optum, a health services platform that provides pharmacy benefits, data analytics, and direct patient care. In an effort to support profitability, the company expects to lose up to 2.8 million members after increasing rates in response to rising medical costs. Shares recently dropped 20% following the release of fourth-quarter (Q4) results due in part to a rising medical care ratio (MCR) that reached 91.5%, its highest level since costs spiked last year. Making matters worse for the insurer, a proposed 0.09% increase for 2027 Medicare Advantage rates, well below industry expectations, arrived before the earnings release. Adding to the uncertainty is the ongoing Department of Justice (DOJ) criminal investigation into Medicare billing practices. Despite the ongoing uncertainty, the 3.2% dividend is safe. The business generated $16 billion in free cash flow (FCF) last year, funding the payout nearly twice over, and management expects earnings per share (EPS) growth of around 8.5% this year. After its recent retreat, the stock trades for 15.5 times next year's earnings target of $17.75 per share. A Nashville icon hiding in plain sight Ryman Hospitality Properties (RHP +0.57%) is a real estate investment trust (REIT) that owns large-scale convention resorts and iconic country music venues. Its portfolio features five of the seven largest non-g...
Teladoc Health saw a serious boom during the COVID-19 pandemic, but with stagnant and declining revenue and a lack of profitability, this company looks like it might end up as a relic of a brief but bygone era. Though it's mercifully beginning to feel like a distant memory now, the aftereffects of the COVID-19 pandemic are still very much with us, though some have faded away faster than others. An...
Teladoc Health saw a serious boom during the COVID-19 pandemic, but with stagnant and declining revenue and a lack of profitability, this company looks like it might end up as a relic of a brief but bygone era. Though it's mercifully beginning to feel like a distant memory now, the aftereffects of the COVID-19 pandemic are still very much with us, though some have faded away faster than others. And Teladoc Health's (TDOC 3.81%) share price is proof of that. There were a handful of companies back in 2020 that had incredible bull runs as the pandemic confined many to their homes. Teladoc was one of them. Teladoc, which offers a specialized place for doctors and patients to hold remote appointments, was founded back in 2002 and had its initial public offering (IPO) in 2015. And it had pretty steady share price growth from 2015 to 2020. Then, during the pandemic, Teladoc, Zoom, and other video-call programs saw explosive growth. When China first reported COVID-19 cases breaking out across the country in late 2019, Teladoc was trading for about $81 per share. Over the course of the next year the stock surged 224% and hit $263 per share in late January 2021. But then came the vaccine, and a slackening of pandemic-era restrictions, and by the end of 2023 life had mostly returned to normal. Unfortunately for Teladoc, so had its share price. The company finished 2023 at $21 per share, lower than it was pre-pandemic and a 92% decrease from its peak. Today it only trades for about $5, and even at these prices I wouldn't give Teladoc a look. It's fundamentally weak and lacks a real moat to protect itself. Expand NYSE : TDOC Teladoc Health Today's Change ( -3.81 %) $ -0.18 Current Price $ 4.67 Key Data Points Market Cap $861M Day's Range $ 4.54 - $ 4.83 52wk Range $ 4.54 - $ 15.21 Volume 235K Avg Vol 5.8M Gross Margin 55.61 % Somebody call a doctor Teladoc has one glaring problem shared by most of the video calling companies like it. There's a lot of competition, and it's easy t...
Key Points Ryman Hospitality offers investors a unique opportunity to earn income while investing in Music City. ONEOK’s diversified midstream scale supports strong cash-flow growth. UnitedHealth shares are at multiyear lows as it chooses margins over member count. 10 stocks we like better than UnitedHealth Group › In a market where income investors have options, the 10-year Treasury yield of 4.2%...
Key Points Ryman Hospitality offers investors a unique opportunity to earn income while investing in Music City. ONEOK’s diversified midstream scale supports strong cash-flow growth. UnitedHealth shares are at multiyear lows as it chooses margins over member count. 10 stocks we like better than UnitedHealth Group › In a market where income investors have options, the 10-year Treasury yield of 4.2% serves as a "risk-free" rate. It represents the guaranteed return on government debt where principal loss is virtually non-existent. To compete with the relatively high rate, a dividend stock must offer price appreciation and growth potential backed by solid coverage ratios. These three companies fit that bill. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Trading members for pricing discipline UnitedHealth Group (NYSE: UNH) operates the nation's largest private health insurer, alongside Optum, a health services platform that provides pharmacy benefits, data analytics, and direct patient care. In an effort to support profitability, the company expects to lose up to 2.8 million members after increasing rates in response to rising medical costs. Shares recently dropped 20% following the release of fourth-quarter (Q4) results due in part to a rising medical care ratio (MCR) that reached 91.5%, its highest level since costs spiked last year. Making matters worse for the insurer, a proposed 0.09% increase for 2027 Medicare Advantage rates, well below industry expectations, arrived before the earnings release. Adding to the uncertainty is the ongoing Department of Justice (DOJ) criminal investigation into Medicare billing practices. Despite the ongoing uncertainty, the 3.2% dividend is safe. The business generated $16 billion in free cash flow (FCF) last year, funding the payout nearly twice over, and management expects earnings per share (EPS) growth of ar...
Key Points Teladoc has seen its share price tumble 98% from its 2021 peak. It has declining revenue and is not profitable. The company has lots of competition and lacks a moat to protect itself or meaningfully set itself apart from the competition. 10 stocks we like better than Teladoc Health › Though it's mercifully beginning to feel like a distant memory now, the aftereffects of the COVID-19 pan...
Key Points Teladoc has seen its share price tumble 98% from its 2021 peak. It has declining revenue and is not profitable. The company has lots of competition and lacks a moat to protect itself or meaningfully set itself apart from the competition. 10 stocks we like better than Teladoc Health › Though it's mercifully beginning to feel like a distant memory now, the aftereffects of the COVID-19 pandemic are still very much with us, though some have faded away faster than others. And Teladoc Health's (NYSE: TDOC) share price is proof of that. There were a handful of companies back in 2020 that had incredible bull runs as the pandemic confined many to their homes. Teladoc was one of them. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Teladoc, which offers a specialized place for doctors and patients to hold remote appointments, was founded back in 2002 and had its initial public offering (IPO) in 2015. And it had pretty steady share price growth from 2015 to 2020. Then, during the pandemic, Teladoc, Zoom, and other video-call programs saw explosive growth. When China first reported COVID-19 cases breaking out across the country in late 2019, Teladoc was trading for about $81 per share. Over the course of the next year the stock surged 224% and hit $263 per share in late January 2021. But then came the vaccine, and a slackening of pandemic-era restrictions, and by the end of 2023 life had mostly returned to normal. Unfortunately for Teladoc, so had its share price. The company finished 2023 at $21 per share, lower than it was pre-pandemic and a 92% decrease from its peak. Today it only trades for about $5, and even at these prices I wouldn't give Teladoc a look. It's fundamentally weak and lacks a real moat to protect itself. Somebody call a doctor Teladoc has one glaring problem shared by most of the video calling companies like it. There's a lot ...
Launch Complex 39A at NASA's Kennedy Space Center in Florida is accustomed to getting makeovers. It got another one Wednesday with the removal of the Crew Access Arm used by astronauts to board their rides to space. Construction workers first carved the footprint for the launch pad from the Florida wetlands more than 60 years ago. NASA used the site to launch Saturn V rockets dispatching astronaut...
Launch Complex 39A at NASA's Kennedy Space Center in Florida is accustomed to getting makeovers. It got another one Wednesday with the removal of the Crew Access Arm used by astronauts to board their rides to space. Construction workers first carved the footprint for the launch pad from the Florida wetlands more than 60 years ago. NASA used the site to launch Saturn V rockets dispatching astronauts to the Moon, then converted the pad for the Space Shuttle program. The last shuttle flight lifted off from Pad 39A in 2011, and the agency leased the site to SpaceX for use as the departure point for the company's Falcon 9 and Falcon Heavy rockets. SpaceX started launching from Pad 39A in 2017, then installed a new Crew Access Arm on the pad's tower the following year, replacing the aging shuttle-era arm that connected to the hatches of NASA's orbiters. SpaceX added the new arm ahead of the first test flight of the company's human-rated Crew Dragon spacecraft in 2019. Astronauts started using the pathway, suspended more than 200 feet above the pad surface, beginning with the first crew flight on a Dragon spacecraft in 2020. Read full article Comments